H.R. 4780 · 119th Congress (2025–2027)
USTRx Act
This bill establishes the role of Chief Pharmaceutical Trade Negotiator within the Office of the U.S. Trade Representative (USTR). The negotiator must conduct trade negotiations, enforce trade agreements relating to U.S. pharmaceutical products, and address acts, policies, or practices of high-income countries that adversely impact the market access of U.S. pharmaceutical manufacturers.
The USTR must annually compile a list of high-income countries based on official statistics of the International Bank for Reconstruction and Development of the World Bank. Based on that list, the negotiator must submit a report describing (1) such countries' actions and impacts relating to the pharmaceutical trade, and (2) the current status of any responsive actions taken by the United States.
The bill also requires the USTR to submit to Congress a plan to respond to certain adverse acts, policies, or practices of high-income countries that are related to the trade of pharmaceutical products.
Show official title
To identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 4780’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Jodey C. Arrington (R-TX-19)
- Cosponsors
8 cosponsors
4 original · 4 later
8 R
- Rep. Vern Buchanan (R-FL-16)· Original · Jul 29, 2025
- Rep. Charles J. "Chuck" Fleischmann (R-TN-3)· Original · Jul 29, 2025
- Rep. Gregory F. Murphy (R-NC-3)· Original · Jul 29, 2025
- Rep. Claudia Tenney (R-NY-24)· Original · Jul 29, 2025
- Rep. Carol D. Miller (R-WV-1)· Later · Aug 5, 2025
- Rep. James R. Baird (R-IN-4)· Later · Mar 27, 2026
- Rep. Nathaniel Moran (R-TX-1)· Later · Apr 20, 2026
- Rep. W. Gregory Steube (R-FL-17)· Later · Jul 21, 2026
- Policy area
- Foreign Trade and International Finance
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the House Committee on Ways and Means.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
USTRx Act
Display title, Short title · Introduced in House
Use Sovereignty To reduce Rx Act
Short title · Introduced in House
To identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.
Official title · Introduced in House